A Comparative Study of Two Regimens of Combination Chemotherapy in Acute Leukemia

Abstract

Background
Acute leukemia is a heterogeneous group of malignancies characterized by the rapid
proliferation of immature blood cells. This study aims to compare the efficacy and safety of
two different regimens of combination chemotherapy in patients diagnosed with acute
leukemia.
Materials and Methods
A total of 120 patients with acute leukemia were randomly assigned to two treatment groups:
Regimen A (cytarabine and daunorubicin) and Regimen B (cytarabine, daunorubicin, and
etoposide). Patients were evaluated based on complete remission rates, overall survival, and
adverse effects over a 12-month period.